Bausch Health Companies Inc (BHC) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.213x

Based on the latest financial reports, Bausch Health Companies Inc (BHC) has a cash flow conversion efficiency ratio of -0.213x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$230.00 Million ≈ $166.38 Million USD) by net assets (CA$-1.08 Billion ≈ $-782.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Bausch Health Companies Inc (BHC) liquidity interval to measure how many days the company can operate on defensive assets alone.

Bausch Health Companies Inc - Cash Flow Conversion Efficiency Trend (1993–2025)

This chart illustrates how Bausch Health Companies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bausch Health Companies Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bausch Health Companies Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Droneshield Ltd
AU:DRO
-0.013x
CETC Digital Technology Co Ltd
SHG:600850
0.020x
Beijing Dabeinong Technology Group Co Ltd
SHE:002385
0.050x
Farglory Land Development Co Ltd
TW:5522
0.056x
China Yuchai International Limited
NYSE:CYD
N/A
G2 Goldfields Inc.
TO:GTWO
-0.003x
Shenzhen Forms Syntron Information Co Ltd
SHE:300468
0.070x
S-1 Corp
KO:012750
0.070x

Annual Cash Flow Conversion Efficiency for Bausch Health Companies Inc (1993–2025)

The table below shows the annual cash flow conversion efficiency of Bausch Health Companies Inc from 1993 to 2025. For the full company profile with market capitalisation and key ratios, see Bausch Health Companies Inc stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CA$376.31 Million
≈ $272.22 Million
CA$1.38 Billion
≈ $997.34 Million
3.664x +173.87%
2024-12-31 CA$-322.00 Million
≈ $-232.93 Million
CA$1.60 Billion
≈ $1.16 Billion
-4.960x +60.59%
2023-12-31 CA$-82.00 Million
≈ $-59.32 Million
CA$1.03 Billion
≈ $746.53 Million
-12.585x -349.48%
2022-12-31 CA$260.00 Million
≈ $188.08 Million
CA$-728.00 Million
≈ $-526.62 Million
-2.800x +93.32%
2021-12-31 CA$-34.00 Million
≈ $-24.60 Million
CA$1.43 Billion
≈ $1.03 Billion
-41.941x -2383.93%
2020-12-31 CA$605.00 Million
≈ $437.65 Million
CA$1.11 Billion
≈ $803.68 Million
1.836x +38.98%
2019-12-31 CA$1.14 Billion
≈ $821.77 Million
CA$1.50 Billion
≈ $1.09 Billion
1.321x +147.80%
2018-12-31 CA$2.81 Billion
≈ $2.04 Billion
CA$1.50 Billion
≈ $1.09 Billion
0.533x +38.40%
2017-12-31 CA$5.94 Billion
≈ $4.30 Billion
CA$2.29 Billion
≈ $1.66 Billion
0.385x -39.86%
2016-12-31 CA$3.26 Billion
≈ $2.36 Billion
CA$2.09 Billion
≈ $1.51 Billion
0.641x +75.54%
2015-12-31 CA$6.03 Billion
≈ $4.36 Billion
CA$2.20 Billion
≈ $1.59 Billion
0.365x -13.58%
2014-12-31 CA$5.43 Billion
≈ $3.93 Billion
CA$2.29 Billion
≈ $1.66 Billion
0.422x +112.08%
2013-12-31 CA$5.23 Billion
≈ $3.79 Billion
CA$1.04 Billion
≈ $753.74 Million
0.199x +12.73%
2012-12-31 CA$3.72 Billion
≈ $2.69 Billion
CA$656.58 Million
≈ $474.96 Million
0.177x +4.62%
2011-12-31 CA$4.01 Billion
≈ $2.90 Billion
CA$676.47 Million
≈ $489.35 Million
0.169x +215.02%
2010-12-31 CA$4.91 Billion
≈ $3.55 Billion
CA$263.19 Million
≈ $190.39 Million
0.054x -79.89%
2009-12-31 CA$1.35 Billion
≈ $979.73 Million
CA$360.90 Million
≈ $261.07 Million
0.266x +56.71%
2008-12-31 CA$1.20 Billion
≈ $869.22 Million
CA$204.32 Million
≈ $147.81 Million
0.170x -35.25%
2007-12-31 CA$1.30 Billion
≈ $938.82 Million
CA$340.85 Million
≈ $246.57 Million
0.263x -35.35%
2006-12-31 CA$1.28 Billion
≈ $929.45 Million
CA$521.93 Million
≈ $377.56 Million
0.406x +12.50%
2005-12-31 CA$1.38 Billion
≈ $997.94 Million
CA$498.11 Million
≈ $360.32 Million
0.361x +77.00%
2004-12-31 CA$1.36 Billion
≈ $982.59 Million
CA$277.09 Million
≈ $200.44 Million
0.204x -36.22%
2003-12-31 CA$881.60 Million
≈ $637.73 Million
CA$281.98 Million
≈ $203.98 Million
0.320x -19.04%
2002-12-31 CA$845.69 Million
≈ $611.76 Million
CA$334.10 Million
≈ $241.69 Million
0.395x +56.58%
2001-12-31 CA$1.13 Billion
≈ $814.58 Million
CA$284.12 Million
≈ $205.53 Million
0.252x -41.54%
2000-12-31 CA$237.46 Million
≈ $171.77 Million
CA$102.49 Million
≈ $74.14 Million
0.432x +131.96%
1999-12-31 CA$435.30 Million
≈ $314.89 Million
CA$81.00 Million
≈ $58.59 Million
0.186x -82.23%
1998-12-31 CA$51.20 Million
≈ $37.04 Million
CA$53.60 Million
≈ $38.77 Million
1.047x +1738.12%
1997-12-31 CA$75.50 Million
≈ $54.62 Million
CA$4.30 Million
≈ $3.11 Million
0.057x +137.53%
1996-12-31 CA$36.90 Million
≈ $26.69 Million
CA$-5.60 Million
≈ $-4.05 Million
-0.152x -107.12%
1995-12-31 CA$14.60 Million
≈ $10.56 Million
CA$31.10 Million
≈ $22.50 Million
2.130x +530.85%
1994-12-31 CA$7.70 Million
≈ $5.57 Million
CA$2.60 Million
≈ $1.88 Million
0.338x -58.19%
1993-12-31 CA$-2.60 Million
≈ $-1.88 Million
CA$-2.10 Million
≈ $-1.52 Million
0.808x --

About Bausch Health Companies Inc

TO:BHC Canada Drug Manufacturers - Specialty & Generic
Market Cap
$1.87 Billion
CA$2.59 Billion CAD
Market Cap Rank
#6538 Global
#206 in Canada
Share Price
CA$6.93
Change (1 day)
-0.72%
52-Week Range
CA$6.82 - CA$11.52
All Time High
CA$213.05
About

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmac… Read more